Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biote (BTMD) Receivables (2021 - 2025)

Biote (BTMD) has 5 years of Receivables data on record, last reported at $8.0 million in Q3 2025.

  • For Q3 2025, Receivables fell 6.13% year-over-year to $8.0 million; the TTM value through Sep 2025 reached $8.0 million, down 6.13%, while the annual FY2024 figure was $7.6 million, 12.07% up from the prior year.
  • Receivables reached $8.0 million in Q3 2025 per BTMD's latest filing, down from $9.1 million in the prior quarter.
  • Across five years, Receivables topped out at $10.2 million in Q3 2023 and bottomed at $5.2 million in Q4 2021.
  • Average Receivables over 5 years is $7.8 million, with a median of $7.7 million recorded in 2024.
  • Peak YoY movement for Receivables: skyrocketed 33.29% in 2023, then decreased 16.55% in 2024.
  • A 5-year view of Receivables shows it stood at $5.2 million in 2021, then surged by 32.82% to $6.9 million in 2022, then dropped by 2.0% to $6.8 million in 2023, then increased by 12.07% to $7.6 million in 2024, then increased by 4.47% to $8.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Receivables were $8.0 million in Q3 2025, $9.1 million in Q2 2025, and $7.8 million in Q1 2025.